Arovella Therapeutics Ltd
ASX:ALA

Watchlist Manager
Arovella Therapeutics Ltd Logo
Arovella Therapeutics Ltd
ASX:ALA
Watchlist
Price: 0.18 AUD -5.26% Market Closed
Market Cap: 189.3m AUD
Have any thoughts about
Arovella Therapeutics Ltd?
Write Note

Arovella Therapeutics Ltd
Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Arovella Therapeutics Ltd
Common Stock Peer Comparison

Comparables:
MYX
NEU
BOT
PBP
VLS

Competitive Common Stock Analysis
Latest Figures & CAGR of Competitors

Company Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
Arovella Therapeutics Ltd
ASX:ALA
Common Stock
AU$104.3m
CAGR 3-Years
11%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Mayne Pharma Group Ltd
ASX:MYX
Common Stock
AU$1.2B
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Common Stock
AU$175.7m
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
5%
Botanix Pharmaceuticals Ltd
ASX:BOT
Common Stock
AU$188.3m
CAGR 3-Years
38%
CAGR 5-Years
41%
CAGR 10-Years
22%
Probiotec Ltd
ASX:PBP
Common Stock
AU$53.2m
CAGR 3-Years
2%
CAGR 5-Years
8%
CAGR 10-Years
5%
Vita Life Sciences Ltd
ASX:VLS
Common Stock
AU$46.4m
CAGR 3-Years
4%
CAGR 5-Years
2%
CAGR 10-Years
0%

See Also

What is Arovella Therapeutics Ltd's Common Stock?
Common Stock
104.3m AUD

Based on the financial report for Jun 30, 2024, Arovella Therapeutics Ltd's Common Stock amounts to 104.3m AUD.

What is Arovella Therapeutics Ltd's Common Stock growth rate?
Common Stock CAGR 5Y
9%

Over the last year, the Common Stock growth was 17%. The average annual Common Stock growth rates for Arovella Therapeutics Ltd have been 11% over the past three years , 9% over the past five years .

Back to Top